Brii Biosciences Limited (BRIBF)
USD 0.13
(0.0%)
USD 0.13
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 617 Thousand CNY | -3.62% |
| 2022 | 565.81 Million CNY | -11.95% |
| 2021 | 642.61 Million CNY | -29.53% |
| 2020 | 911.88 Million CNY | 618.45% |
| 2019 | 126.92 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 16.35 Million USD | 0.0% |
| 2024 Q1 | 16.46 Million USD | -19.2% |
| 2023 Q4 | 39.7 Million USD | 97.05% |
| 2023 FY | 545.34 Million CNY | -3.62% |
| 2023 Q3 | 20.15 Million USD | -53.11% |
| 2023 Q2 | 42.97 Million USD | 92.66% |
| 2023 Q1 | 22.3 Million USD | -39.83% |
| 2022 Q2 | 55.53 Million USD | 0.0% |
| 2022 FY | 565.81 Million CNY | -11.95% |
| 2022 Q4 | 37.06 Million USD | 0.0% |
| 2021 FY | 642.61 Million CNY | -29.53% |
| 2021 Q4 | 72.65 Million USD | 0.0% |
| 2021 Q2 | 33.62 Million USD | 0.0% |
| 2020 Q2 | 42.77 Million USD | 0.0% |
| 2020 FY | 911.88 Million CNY | 618.45% |
| 2020 Q4 | 98.06 Million USD | 0.0% |
| 2019 FY | 126.92 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 86.78 Million USD | 99.289% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 87.454% |
| SQZ Biotechnologies Company | 85.61 Million USD | 99.279% |
| Evofem Biosciences, Inc. | 29.55 Million USD | 97.912% |
| Santhera Pharmaceuticals Holding AG | 37.25 Million USD | 98.344% |
| Mesoblast Limited | 5.9 Million USD | 89.546% |
| Propanc Biopharma, Inc. | 1.5 Million USD | 58.919% |
| Genus plc | 147.7 Million USD | 99.582% |
| VioQuest Pharmaceuticals, Inc. | 8.77 Million USD | 92.972% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | 54.008% |
| Marizyme, Inc. | 19.23 Million USD | 96.793% |
| ContraFect Corporation | 56.88 Million USD | 98.915% |
| Nymox Pharmaceutical Corporation | 8.33 Million USD | 92.601% |
| PsyBio Therapeutics Corp. | 4.4 Million USD | 86.005% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.47 Million USD | 58.276% |
| Intellipharmaceutics International Inc. | 2.91 Million USD | 78.843% |
| AXIM Biotechnologies, Inc. | 2.79 Million USD | 77.888% |
| MultiCell Technologies, Inc. | 567.42 USD | -108637.796% |
| Accustem Sciences Inc. | 3.74 Million USD | 83.531% |
| RVL Pharmaceuticals plc | 85.94 Million USD | 99.282% |
| EV Biologics, Inc. | 531.96 Thousand USD | -15.986% |
| Q BioMed Inc. | 3.43 Million USD | 82.046% |
| Emmaus Life Sciences, Inc. | 24.71 Million USD | 97.504% |
| Neon Bloom, Inc. | 389.56 Thousand USD | -58.381% |
| Mosaic ImmunoEngineering Inc. | 2.62 Million USD | 76.518% |
| Biomind Labs Inc. | 994.18 Thousand USD | 37.939% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 225.49 Million USD | 99.726% |
| Oncotelic Therapeutics, Inc. | 6.71 Million USD | 90.816% |
| Skye Bioscience, Inc. | 13.54 Million USD | 95.446% |
| Therapeutic Solutions International, Inc. | 2.04 Million USD | 69.883% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | 2568.0% |
| Arch Therapeutics, Inc. | 5.04 Million USD | 87.763% |
| IMV Inc. | 37.7 Million USD | 98.364% |
| Acro Biomedical Co., Ltd. | 16.01 Million USD | 96.146% |
| Curative Biotechnology, Inc. | 1.83 Million USD | 66.378% |
| GB Sciences, Inc. | 1.42 Million USD | 56.565% |
| Alpha Cognition Inc. | 9.7 Million USD | 93.643% |
| HST Global, Inc. | 140.9 Thousand USD | -337.877% |
| CSL Limited | 3.44 Billion USD | 99.982% |
| Halberd Corporation | 74.84 Thousand USD | -724.403% |
| Enzolytics Inc. | 2.17 Million USD | 71.691% |
| Resverlogix Corp. | 12.71 Million USD | 95.146% |
| Affymax, Inc. | 39.38 Million USD | 98.433% |
| SYBLEU INC | 160.87 Thousand USD | -283.525% |
| Nuo Therapeutics, Inc. | 3.65 Million USD | 83.099% |
| argenx SE | 1.53 Billion USD | 99.96% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 57.44 Million USD | 98.926% |
| Enzon Pharmaceuticals, Inc. | 1.04 Million USD | 40.9% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 1.57 Million USD | 60.933% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 3.4 Million USD | 81.879% |
| AVAX Technologies, Inc. | 7.31 Million USD | 91.56% |
| Zenith Capital Corp. | 8.94 Million USD | 93.101% |
| Genscript Biotech Corporation | 825.34 Million USD | 99.925% |
| Ember Therapeutics, Inc. | 17.42 Thousand USD | -3441.703% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.45 Million USD | 74.871% |
| WPD Pharmaceuticals Inc. | 171.5 Thousand USD | -259.748% |
| American Oriental Bioengineering, Inc. | 99.33 Million USD | 99.379% |
| Provectus Biopharmaceuticals, Inc. | 1.75 Million USD | 64.937% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 1.97 Million USD | 68.713% |
| GlobeStar Therapeutics Corporation | 1.86 Million USD | 66.906% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 10.86 Million USD | 94.322% |
| Cotinga Pharmaceuticals Inc. | 1.92 Million USD | 67.88% |
| BioStem Technologies, Inc. | 22.97 Million USD | 97.314% |
| ONE Bio Corp. | 6.44 Million USD | 90.425% |
| Reve Technologies, Inc. | 181.48 Thousand USD | -239.973% |
| Burzynski Research Institute, Inc. | 1.33 Million USD | 53.798% |
| Wesana Health Holdings Inc. | 1.12 Million USD | 45.151% |
| Agentix Corp. | 1.37 Million USD | 55.021% |
| LadRx Corporation | 3.81 Million USD | 83.813% |
| Cell Source, Inc. | 4.32 Million USD | 85.735% |
| ProtoKinetix, Incorporated | 415.47 Thousand USD | -48.503% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | 33.19% |
| Regen BioPharma, Inc. | 923.51 Thousand USD | 33.19% |
| NovAccess Global Inc. | 2.46 Million USD | 74.987% |
| Endonovo Therapeutics, Inc. | 2.4 Million USD | 74.344% |
| Itoco Inc. | 919.14 Thousand USD | 32.872% |
| Rasna Therapeutics, Inc. | 4.23 Million USD | 85.443% |
| Pathfinder Cell Therapy, Inc. | 1.11 Million USD | 44.861% |
| Kadimastem Ltd | 2.41 Million USD | 74.4% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 261.72 Thousand USD | -135.743% |
| CytoDyn Inc. | 18.05 Million USD | 96.583% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 25.16 Thousand USD | -2351.428% |
| Mobile Lads Corp. | 554.54 Thousand USD | -11.262% |
| NanoSphere Health Sciences Inc. | 220.07 Thousand USD | -180.355% |
| Qrons Inc. | 643.67 Thousand USD | 4.144% |
| Alseres Pharmaceuticals, Inc. | 1.41 Million USD | 56.543% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 2.22 Million USD | 72.33% |
| Rebus Holdings, Inc. | 664 Thousand USD | 7.078% |
| ImmunoCellular Therapeutics, Ltd. | 1.81 Million USD | 66.03% |
| International Stem Cell Corporation | 5.27 Million USD | 88.294% |
| Bioxytran, Inc. | 3.82 Million USD | 83.849% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 52.64 Thousand USD | -1072.068% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 20.34 Thousand USD | -2932.984% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 36.26 Million USD | 98.299% |
| Adhera Therapeutics, Inc. | 1.61 Million USD | 61.867% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 735.83 Thousand USD | 16.15% |
| Innovation Pharmaceuticals Inc. | 3.11 Million USD | 80.167% |
| Neutra Corp. | 243.82 Thousand USD | -153.054% |
| Windtree Therapeutics, Inc. | 17.45 Million USD | 96.466% |
| PureTech Health plc | 144.59 Million USD | 99.573% |
| Coeptis Therapeutics, Inc. | 20.48 Million USD | 96.989% |
| IXICO plc | 4.7 Million USD | 86.892% |
| IntelGenx Technologies Corp. | 8.79 Million USD | 92.986% |
| Gelesis Holdings, Inc. | 117.74 Million USD | 99.476% |
| CSL Limited | 3.89 Billion USD | 99.984% |
| Cellectis S.A. | 97.32 Million USD | 99.366% |